Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes

Contributions to Nephrology

Volumn 125, Issue , 1999, Pages 133-158

  Buoncristiani, U ^a   Galli, F ^b   Benedetti, S ^b   Errico, R ^a   Beninati, S ^c   Ghibelli, L ^c   Floridi, A ^d   Canestrari, F ^b  

^a Ospedale Silvestrini   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 FUROIC ACID; 2-FUROIC ACID; AM 160H; BETA 2 MICROGLOBULIN; BIOMATERIAL; CELLULOSE; CYTOKINE; DRUG; DRUG DERIVATIVE; FURAN DERIVATIVE; GLYCOCONJUGATE; PLASMA PROTEIN; POLY(METHYL METHACRYLATE); POLYMER; REACTIVE OXYGEN METABOLITE; SERUM ALBUMIN;

AMYLOIDOSIS; ANEMIA; APOPTOSIS; ARTIFICIAL MEMBRANE; CHEMISTRY; DIFFUSION; ERYTHROPOIESIS; HUMAN; INSTRUMENTATION; METABOLISM; MOLECULAR WEIGHT; NEUTROPHIL; PERMEABILITY; RENAL REPLACEMENT THERAPY; REVIEW; SECRETION; UREMIA;

AMYLOIDOSIS; ANEMIA; APOPTOSIS; BETA 2-MICROGLOBULIN; BIOCOMPATIBLE MATERIALS; BLOOD PROTEINS; CELLULOSE; CYTOKINES; DIFFUSION; ERYTHROPOIESIS; FURANS; GLYCOCONJUGATES; HUMANS; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; NEUTROPHILS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; POLYMERS; POLYMETHYL METHACRYLATE; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; SERUM ALBUMIN; UREMIA;

EID: 0032608528     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (72)

1. Sakai Y, Tanzawa H: Polymethylmethacrylate membranes. J Appl Sci 1978;22:1805-1818.
2. 2-microglobulin removal by PMMA BK membrane. Nephrol Dial Transplant 1991(suppl2): 69-74.
3. Hakim RM, Fearon DT, Lazarus JM: Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 1984;26:194-200.
4. Tetta C, Camussi G, Turello E, et al: Production of cytokines in hemodialysis. Blood Purif 1990; 8:337-346.
5. Ringoir S: An update on uremic toxins. Kidney Int Suppl 1997;62:S2-S4.
6. Vanholder R, Van Loo A, Dhondt AM, et al: Second symposium on uraemic toxicity (congress report). Nephrol Dial Transplant 1995;10:414-418.
7. 2-microglobulin during hemodialysis using polysulphone, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes. Int J Artif Organs 1989;12:697-702.
8. Bonomini M, Fiederling B, Bucciarelli T, et al: A new polymethylmethacrylate membrane for hemodialysis. Int J Artif Organs 1996;19:232-239.
9. Kobayashi H, Ono T, Yamamoto M, et al: Removal and characterization of hemopoiesis inhibitors using a large-pore membrane (in Japanese). Kidney Dialysis 1993;34(suppl):154-157.
10. 2-microglobulin. Biochem Biophys Res Commun 1985;129:701-706.
11. 2-Microglobulin amyloidosis in chronic dialysis patients: A case report and review of the literature. J Am Soc Nephrol 1997;8:509-514.
12. Jindal KK, McDougall J, Woods B, et al: A study of the basic principles determining the performance of several HF dialyzers. Am J Kidney Dis 1989;14:507-511.
13. Schaefer RM, Huber L, Gilge U, et al: Clinical evaluation of a new HF cellulose acetate membrane. Int J Artif Organs 1989;12:85-90.
14. Kuchle C, Fricke H, Held E, et al: HF hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 1996;16:484-488.
15. Sato M, Koyama M, Miyazaki T, et al: Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients. Nephron 1996;74:419-421.
16. Niwa T, Takeda N, Maeda K, et al: Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding. Clin Chim Acta 1988;173:127-138.
17. Mabuchi H, Nakahashi H: Inhibition of hepatic glutathione S-transferase by a major endogenous ligand substance present in uremic serum. Nephron 1988;49:281-283.
18. Sakai T, Takadate A, Otagiri M: Characterization of binding site of uremic toxins on human serum albumin. Biol Pharm Bull 1995;18:1755-1761.
19. Niwa T, Aiuchi T, Nakaya K, et al: Inhibition of mitochondrial respiration by furancarboxylic acid accumulated in uremic serum in its albumin-bound and non-dialyzable form. Clin Nephrol 1993; 39:92-96.
20. Niwa T, Yazawa T, Kodama T, et al: Efficient removal of albumin bound furancarboxylic acid, an inhibitor of erythropoiesis, by CAPD. Nephron 1990;56:241-245.
21. Spustovà V, Sebekovà K, Drùrik R: Modulators participating in carbohydrate metabolism disturbance in renal disease. Proc 2nd Symp on Uraemic Toxicity, Ghent, Sept 1994.
22. Spustovà V, Dzurik R, Gerykova M: Hippurate participation in the inhibition of glucose utilization in renal failure. Czech Med 1987;10:79-89.
23. Niwa T, Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994;124:96-104.
24. Niwa T, Asada H, Tsutsui S, et al: Efficient removal of albumin-bound furancarboxylic acid by protein-leaking hemodialysis. Am J Nephrol 1995;15:463-467.
25. Rice-Evans CA, Gopinathan V: Oxygen toxicity, free radicals and antioxidant in human disease: Biochemical implications in atherosclerosis and the problems of premature neonates; in Apps DK, Tipton KF (eds): Essays in Biochemistry. London, Portland Press, 1995.
26. Ford-Hutchinson AW, Bray MA, Doig MV, et al: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear. Nature 1980;286:264-265.
27. 4. J Biol Chem 1988;263:174-181.
28. 2-microglobulin amyloidosis. Clin Chim Acta 1993;220:135-144.
29. Wegmuller E, Montandon A, Nydegger U, et al: Biocompatibility of different hemodialysis membrane: Activation of complement and leukopenia. Int J Artif Organs 1986;9:85-92.
30. Haag-Weber M, Schollmeyer P, Hörl WH: Neutrophil activation during hemodialysis. Adv Exp Med Biol 1989;260:27-37.
31. Akizawa T, Nishiyama H, Koshikawa S: Plasma β-thromboglobulin levels in chronic renal failure patients. Int Soc Artif Organs 1981;5:54-58.
32. Horl WH, Riegel W, Schollmeyer P, et al: Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. Clin Nephrol 1986;25:304-307.
33. Magi E, Bellazzi R, Falaschi F, et al: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45:876-883.
34. Cornelius RM, Brash JL: Identification of proteins absorbed to hemodialyser membranes from heparinized plasma. J Biomater Sci Polym Ed 1993;4:291-304.
35. Niwa T, Fujishiro T, Uema K, et al: Effect of hemodialysis on plasma levels of vasoactive peptides: Endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide. Nephron 1993; 64:552-559.
36. Tetta C, Cioni A, Camussi G: Biocompatibility: Still a challenge. J Nephrol 1992;5:14-22.
37. Bergesio F, Monzani G, Manescalchi F, et al: Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes; comparison with cuprophan and polyacrylonitrile. Blood Purif 1988;6:16-26.
38. Blumenstein M, Ziegler-Heitbrock HW, Schiller B, et al: Differential activation of monocytes in haemodialysis patients exposed to different types of membranes. Scand J Immunol 1990;31:183-190.
39. Heidenreich S, Schmidt M, Bachmann J, et al: Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 1996;49:792-799.
40. Matsumoto Y, Shinzato T, Amano I, et al: Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients. A possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun 1995;215:98-105.
41. Amore A, Cirina P, Peruzzi L, et al: Acetate-free biofiltration prevents endothelial cell apoptosis induced by nitric oxide. Nephrology 1997;3:P1346.
42. Memoli B, Libetta C, Rampino T, et al: Interleukin-6 production of uraemic haemodialysis patients: Effects of different membranes. Nephrol Dial Transplant 1991;6(suppl 2):96-98.
43. Roccatello D, Mengozzi G, Alfieri V, et al: Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosylhaemoglobin, in haemodialysis. Nephrol Dial Transplant 1997; 12:292-297.
44. Stamler JS: Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 1994; 78:931-936.
45. Stamler JS, Jia L, Eu JP, et al: Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997;276:2034-2037.
46. Schmidt H, Walter U: NO at work. Cell 1994;78:919-925.
47. Galli F, Rovidati S, Ghibelli L, et al: S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase decreases the enzyme affinity to the erythrocyte membrane. Nitric Oxide Biol Chem 1998; 2:17-27.
48. Galli F, Basta G, Ubaldi S, et al: Effects of S-nitrosoglutathione (GSNO) on thiol homeostasis of pancreatic islets. Diabetes Nutr Metab 1997;10:296-299.
49. Tanaka H: Quality of membrane. Contrib Nephrol. Basel, Karger, 1993, vol 103, pp 112-124.
50. Haag-Weber M, Horl WH: The immune system in uremia and during its treatment. New Horiz 1995;3:669-679.
51. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergies with GM-CSF, G-CSF, IL-3 and Epo to stimulate progenitor cells of the myeloid and erythroid lineages. Exp Hematol 1991;19:226-231.
52. Wyllie AH, Ker JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68:251-273.
53. Ghibelli L, Fanelli C, Rotilio G, et al: Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J 1998;12:479-486.
54. Kushner D, Beckman B, Nguyen L, et al: Polyamines in the anemia of end-stage renal disease. Kidney Int 1991;39:725-732.
55. Taniguchi S, Dai CH, Krantz SB: Specific binding of interferon-γ to high-affinity receptors on human erythroid colony-forming cells. Exp Hematol 1997;25:193-198.
56. Schaefer RM, Paczek L, Heidland A: Cytokine production by monocytes during haemodialysis. Nephrol Dial Transplant 1991;6(suppl 2):14-17.
57. Sano H, Asano K, Fujisawa K, et al: An increase of plasma levels of soluble Fas in chronic glomerulonephritis and diabetic nephropathy. Nephrology 1997;3(suppl 1):P662.
58. Amore A, Cirina P, Peruzzi L, et al: Acetate-free biofiltration prevents endothelial cell apoptosis induced by nitric oxide. Nephrology 1997;3(suppl 1):P1346.
59. Vanholder R, Van Loo A, Dhondt AM, et al: Influence of uremia and hemodialysis on host defense and infection. Nephrol Dial Transplant 1996;11:593-598.
60. Galli F, Rovidati S, Chiarantini L, et al: Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int 1998;54:580-589.
61. Carracedo J, et al: Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol 1995;6:1586-1591.
62. Galli F, Ghibelli L, Colussi C, et al: Apoptosi e uremia; in Tecniche nefrologiche e dialitiche. Milano, Bios, 1998.
63. Urban JL, Shephard HN, Rothstein JL, Sugarman BJ, Shreiber H: Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 1986; 83:5233-5237.
64. Parijs LK, Abbas AK: Homeostasis and self-tolerance in the immune system. Turning lymphocytes off. Science 1998;280:243-248.
65. Lutz W: A uremic peptide containing polyamine: Formation and possible role in uremic hypertrigly-ceridemia. Physiol Chem Phys 1980;12:451-456.
66. Bergamini CM, Signorini M, Barbato R, et al: Transglutaminase-catalyzed polymerization of troponin in vitro. Biochem Biophys Res Commun 1995;206:201-206.
67. Cordella-Miele E, Miele L, Beninati S, et al: Transglutaminase-catalyzed incorporation of polyamines into phospholipase A3. J Biochem 1993;113:164-173.
68. Brooks WH: Polyamine involvement in the cell cycle, apoptosis and autoimmunity. Med Hypotheses 1995;44:331-338.
69. Ritz E, Deppish R, Nawroth P: Toxicity of uremia: Does it come of AGE? Nephrol Dial Transplant 1994;9:1-2.
70. Sensi M, Pricci F, Andreani D, et al: Advanced nonenzymatic glycation end-products (AGE): Their relevance to aging and the pathogenesis of late diabetic complications (review). Diabetes Res 1991; 16:1-9.
71. Baumgartner Parzer SM: Glycemia and regulation of endothelial adhesion molecules. Horm Metab Res 1997;29:636-638.
72. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.